RSS
 

Huffington Post: When Testosterone and Corporate Deals Merge

21 Sep

I am now blogging on aging for the Huffington Post. Here’s a taste of my first item:

An academic study with a provocative title landed in my inbox the other day. It’s called “Deal or No Deal: Hormones and the Mergers and Acquisitions Game,” and in it, two finance professors from the University of British Columbia argue that CEOs with high testosterone levels are likely to act recklessly in mergers and acquisitions. Testosterone-laden execs have an outsized propensity to initiate deals, the professors found, but they’re also more likely to rebuff acquisition attempts by rivals, or to scrap deals that are already in progress.

Read more here.

 
Comments Off on Huffington Post: When Testosterone and Corporate Deals Merge

Posted in Testosterone

 

Tags: , , , ,

Comments are closed.